Vnitr Lek 2010, 56(5):370-375

Hormonal contraception and risk of venous thromboembolism

O. Ludka*, J. Špinar, V. Musil, Z. Pozdíšek
Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jindřich Špinar, CSc., FESC

Oral contraceptives increase the risk of thromboembolism. Recent studies have indicated that the risk of thromboembolic disease in users of combined oral contraceptive pills varies not only with estrogen dose, but also with the type of gestagen in pills with the same estrogen dose. We describe 8 women from our intensive care unit who developed a deep venous thrombosis while on oral contraceptives. The aim of this article is also to discuss other risk factors for the potential risk of venous tromboembolism in users of combined oral contraceptive.

Keywords: oral hormonal contraception; venous thromboembolism

Received: December 7, 2009; Accepted: February 11, 2010; Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ludka O, Špinar J, Musil V, Pozdíšek Z. Hormonal contraception and risk of venous thromboembolism. Vnitr Lek. 2010;56(5):370-375.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J 2000; 21: 1301-1336.
    2. Noboa S, Mottier D, Oger E. EPI-GETBO Study Group. Estimation of a potentially preventable fraction of venous thromboembolism: a community-based prospective study. J Thromb Haemost 2006; 4: 2720-2722. Go to original source... Go to PubMed...
    3. Widimsky J, Maly J, Elias P et al. Doporučení diagnostiky, léčby a prevence plicní embolie, verze 2007. Cor Vasa 2008; 50 (Suppl): 1S25-1S72.
    4. Rock J, Garcia CR, Pincus G. Synthetic progestins in the normal human menstrual cycle. Recent Prog Horm Res 1957; 13: 323-339.
    5. Inman WH, Vessey MP, Westerholm B et al. Thromboembolic disease and the steroidal kontent of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J 1970; 2: 203-209. Go to original source... Go to PubMed...
    6. Meade TW, Greenberg G, Thompson SG. Progestogens and cardiovascular actions associated with oral contraceptives and a comparison of the safety of 50 and 30 μg estrogen preparations. Br Med J 1980; 280: 1157-1161. Go to original source... Go to PubMed...
    7. Böttiger LE, Boman G, Eklund G et al. Oral Contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet 1980; 1: 1097-1101. Go to original source... Go to PubMed...
    8. World Health Organisation Collaborative Study on cardiovascular disease and steroid hormone contraception. Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-1588.
    9. Jick H, Jick SS, Gurewitch V et al. Risk of idiopathic cardiovascular death and non fatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-1593. Go to original source... Go to PubMed...
    10. Spitzer WO, Lewis MA, Heinemann L et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996; 312: 83-88. Go to original source... Go to PubMed...
    11. EMEA. Committee for Proprietary Medicinal Products (CPMP) public assessment report on combined oral contraceptives and venous thromboembolism. Available from http://www.emea.EU.int/pdfs/human/reggaffair/0220101en.pdf.
    12. Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 2001; 358: 1427-1429. Go to original source... Go to PubMed...
    13. Lidegaard Ø, Edström B, Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception 2002; 65: 187-196. Go to original source... Go to PubMed...
    14. Lidegaard Ø, Løkkegaard E, Svendsen AL et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009; 339: 557-560. Go to original source... Go to PubMed...
    15. Čepický P, Cibula D, Dvořák K et al. Doporučení k předpisu kombinované hormonální kontracepce (CC). Aktualizace 2005. Čes Gynekol 2005; 70: 465-468.
    16. Dulíček P, Kalousek I. Hormonální antikoncepce a tromboembolická nemoc na konci tisíciletí. Plánování rodiny a reprodukční zdraví 2000; 3: 60-63.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.